Delivery Order SPE2DR25D1202-SPE2DR26F74KL
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,577.02 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on February 2, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. The award is structured as a firm fixed-price delivery order with an ultimate completion date of February 3, 2026. This competitively awarded contract carries no set-aside designation, reflecting Amerisourcebergen's demonstrated capability to compete successfully in open federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $12,049.24. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,126.96 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion deadline of January 9, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a...
- The Defense Logistics Agency awarded a $6,407.90 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 12, 2026. The contract will be performed at Amerisourcebergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This award represents a task order against the...
- The Defense Logistics Agency awarded a delivery order valued at $6,253.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on February 4, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award, operating under its parent organization Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a delivery order valued at $12,954.23 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit packages) on January 27, 2026, with completion expected by January 28, 2026. This non-competitive, firm fixed-price delivery order was fulfilled from the company's place of performance in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,066.42 for Vemlidy 25 mg tablets (30-count units) on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The contract has no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,094.43. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement through open competition. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $10,439.22, with an ultimate completion date of November 25, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,693.37 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-set-aside, firm fixed-price delivery order was awarded competitively and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up...